@pietschmann

Successful anti-SR-BI mAb therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents

, , , , , , , , , , , , , and . Hepatology, 9 (7): e102235 (2014)

Links and resources

Tags